These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18299409)

  • 1. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
    Stepniewska K; White NJ
    Antimicrob Agents Chemother; 2008 May; 52(5):1589-96. PubMed ID: 18299409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
    Krishna S; White NJ
    Clin Pharmacokinet; 1996 Apr; 30(4):263-99. PubMed ID: 8983859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of antimalarials in pregnancy: a systematic review.
    Wilby KJ; Ensom MH
    Clin Pharmacokinet; 2011 Nov; 50(11):705-23. PubMed ID: 21973268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of antimalarial drugs.
    White NJ
    Clin Pharmacokinet; 1985; 10(3):187-215. PubMed ID: 3893840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The de novo selection of drug-resistant malaria parasites.
    White NJ; Pongtavornpinyo W
    Proc Biol Sci; 2003 Mar; 270(1514):545-54. PubMed ID: 12641911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of malaria.
    White NJ
    N Engl J Med; 1996 Sep; 335(11):800-6. PubMed ID: 8703186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
    Simpson JA; Watkins ER; Price RN; Aarons L; Kyle DE; White NJ
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3414-24. PubMed ID: 11083649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali.
    Tekete MM; Toure S; Fredericks A; Beavogui AH; Sangare CP; Evans A; Smith P; Maiga H; Traore ZI; Doumbo OK; Barnes KI; Djimde AA
    Malar J; 2011 Sep; 10():275. PubMed ID: 21936885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
    Marquart L; Baker M; O'Rourke P; McCarthy JS
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4249-59. PubMed ID: 25963983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
    Dow GS; Gettayacamin M; Hansukjariya P; Imerbsin R; Komcharoen S; Sattabongkot J; Kyle D; Milhous W; Cozens S; Kenworthy D; Miller A; Veazey J; Ohrt C
    Malar J; 2011 Jul; 10():212. PubMed ID: 21801400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance.
    He Q; Chaillet JK; Labbé F
    Elife; 2024 Feb; 12():. PubMed ID: 38363295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage sensitivity of Plasmodium vinckei petteri to quinine, mefloquine, and pyrimethamine.
    Caillard V; Beauté-Lafitte A; Chabaud A; Ginsburg H; Landau I
    J Parasitol; 1995 Apr; 81(2):295-301. PubMed ID: 7707210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytochrome P-450 and the response to antimalarial drugs].
    Guzmán V; Carmona-Fonseca J
    Rev Panam Salud Publica; 2006 Jan; 19(1):9-22. PubMed ID: 16536934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.